The group's principal activities are to develop, produce and market minimally invasive medical devices, mainly for urological diseases. The group's operations are carried out through three business divisions: uds, hifu and edap tms. The uds division's primary business is producing and marketing devices, known as lithotripters, for the treatment of urinary tract stones by means of eswl technology. Hifu division of the group develops and markets devices for the minimally invasive destruction of certain types of localized tumors using hifu technology. Edap tms s.a. Is a holding company and is responsible for providing common services to its subsidiaries
